Idelalisib (b)
Idelalisib is a selective inhibitor of p110δ (IC50 : 2.5 nM; in cell-free assays) ; shown to have 40- to 300-fold greater selectivity for p110δ than p110α/β/γ, and 400- to 4000-fold more selectivity to p110δ than C2β, hVPS34, DNA-PK and mTOR.
Product Specifications
CAS Number
1146702-54-6
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
415.42
Molecular Formula
C22H18FN7O
Notes
Research use only, not for human use.
Receptor
P110δ
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
